Tisdag 13 Januari | 13:03:25 Europe / Stockholm
2026-01-13 09:33:00

The 2025 Nobel Prize spotlighted peripheral immune tolerance, a principle increasingly shaping new strategies for autoimmune disease. In a conversation with BioStock, Diamyd Medical board member Dr. Karin Rosén shares why this field is now moving from discovery to development – and how the company is applying the science in autoimmune diabetes.

Read the article at biostock.se:
https://biostock.se/en/2026/01/diamyd-medical-ett-svenskt-exempel-pa-nobelprisbelonad-forskning-i-praktiken/
 
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/